Header image

ADS Clinical Orals: Complications in Type 2 Diabetes: Kidney, Liver, Heart

Tracks
Breakout 5: BelleVue Ballroom 2
Friday, August 23, 2024
11:00 AM - 1:00 PM
BelleVue Ballroom 2

Speaker

Dr Julian Sacre
Postdoctoral Research Officer
Baker Heart and Diabetes Institute

A Multi-country Study of Trends in the Incidence of End-stage Kidney Disease among people with Diabetes

11:00 AM - 11:15 AM

Biography

Dr Julian Sacre is a mid-career researcher who has worked at the Baker Heart and Diabetes Institute since 2012. He is with the Clinical Diabetes and Epidemiology team, and the focus of his research is on cardiorenal complications.
Agenda Item Image
Prof David Simmons
Distinguished Professor of Medicine
Western Sydney University

Characteristics associated with Diabetic Kidney Disease among young adults with type 2 diabetes in a multi-ethnic population in New Zealand

11:30 AM - 11:45 AM

Biography

Kanchana Perera is currently in her 2nd year of her Ph.D., at Western Sydney University under the supervision of Professor David Simmons. Her research focusses on evaluating ethnic disparities in type 2 diabetes and associated complications, particularly diabetic kidney disease, in New Zealand.
Morag Nelson
Head of Medical Affairs, CRM
Boehringer Ingelheim

Cardiorenal Effectiveness of Empagliflozin vs. GLP-1 Receptor Agonists in Patients with Advanced Chronic Kidney Disease: Results from the EMPRISE study

11:45 AM - 12:00 PM

Biography

Dr. Morag Nelson received her PhD from the University of Glasgow and has since worked in roles across academia, government and the pharmaceutical industry. She is currently the Head of Medical Affairs, Cardio Renal Metabolic at Boehringer Ingelheim, Australia.
Agenda Item Image
A/Prof Milan Piya
Clinical Academic Endocrinologist
Western Sydney University

Tirzepatide for the Treatment of Metabolic Dysfunction-associated Steatohepatitis with Liver Fibrosis: results of the SYNERGY-NASH phase 2 trial

12:00 PM - 12:15 PM

Biography

Milan Piya is an A/Prof in Diabetes, Obesity and Metabolism at the School of Medicine, Western Sydney University, as well as a clinical academic endocrinologist at Campbelltown and Camden Hospitals.
Dr Lei Chen
Postdoctoral Research Fellow
Baker Heart and Diabetes Institute

Trends in Liver Disease Mortality in People with and without Diabetes: A multi-national population-based study

12:15 PM - 12:30 PM

Biography

Dr Lei Chen is a postdoctoral researcher in the Diabetes and Population Health Unit at Baker Heart and Diabetes Institute. Her work involves using large datasets to investigate the trends in the incidence and mortality of diabetes across different countries.
Dr Joanna Gong
Phd Student
Baker Heart and Diabetes Institute

Decrease in Heart Failure Mortality lags behind Atherosclerotic Cardiovascular Disease in people with Diabetes

12:30 PM - 12:45 PM

Biography

Dr Joanna Gong is a PhD candidate at the Baker Heart & Diabetes Institute and part-time clinical fellow at the Royal Melbourne Hospital. She is researching the epidemiology of the cardiovascular complications of diabetes, supported by NHMRC and Heart Foundation scholarships.
Dr Habib Francis
Postdoctoral Research Fellow
The University of Sydney

Identification of Proteomics Signature for Vascular Complications in Type 2 Diabetes

12:45 PM - 1:00 PM

Biography

Dr Habib Francis is an early career researcher at the NHMRC Clinical Trials Centre at the University of Sydney. He is currently working on proteomic data from the FIELD study in search for protein signatures associated with the development and progression of diabetes-related micro- and macrovascular complications.
Dr Liza Phillips
Endocrinologist
Mater Hospital

Chairperson

11:00 AM - 1:00 PM

Biography

Agenda Item Image
A/Prof Milan Piya
Clinical Academic Endocrinologist
Western Sydney University

Chairperson

11:00 AM - 1:00 PM

Biography

Associate Professor Milan Piya is a clinical academic endocrinologist at the School of Medicine, Western Sydney University, and Campbelltown & Camden Hospitals. He is research lead for the multidisciplinary publicly funded South Western Sydney Metabolic Rehabilitation and Bariatric Program (SWS MRBP) based in Camden Hospital, NSW. His research focus is on obesity and Type 2 diabetes, particularly in the context of severe complex obesity and associated metabolic and mental health conditions. He is on the council of the Australia New Zealand Obesity Society (ANZOS) and chairs the Campbelltown and Camden Hospital Research Committee.
loading